Centene Unveils Its 2025 Guidance, Reaffirms 2024 Outlook

Zacks12-13

Centene Corporation CNC recently revealed its 2025 outlook at its investor day, reaffirming its 2024 guidance.The company continues to expect premium and service revenues within $143.5-$144.5 billion,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491056543?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WPsJyavAWuG62zKy2OJfPg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1742c873e164807fdc15d34abf611170","is_english":true,"pubTime":"2024-12-13 23:43","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2491056543","market":"us","top_or_hot":-1,"title":"Centene Unveils Its 2025 Guidance, Reaffirms 2024 Outlook","media":"Zacks","content":"<div>\n<p>Centene Corporation CNC recently revealed its 2025 outlook at its investor day, reaffirming its 2024 guidance.The company continues to expect premium and service revenues within $143.5-$144.5 billion,...</p>\n\n<a href=\"https://finance.yahoo.com/news/centene-unveils-2025-guidance-reaffirms-154300107.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Centene Unveils Its 2025 Guidance, Reaffirms 2024 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCentene Unveils Its 2025 Guidance, Reaffirms 2024 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-13 23:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/centene-unveils-2025-guidance-reaffirms-154300107.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Centene Corporation CNC recently revealed its 2025 outlook at its investor day, reaffirming its 2024 guidance.The company continues to expect premium and service revenues within $143.5-$144.5 billion,...</p>\n\n<a href=\"https://finance.yahoo.com/news/centene-unveils-2025-guidance-reaffirms-154300107.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2362540622.SGD","symbol_name":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/centene-unveils-2025-guidance-reaffirms-154300107.html","article_id":"2491056543","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WPsJyavAWuG62zKy2OJfPg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1742c873e164807fdc15d34abf611170"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491056543","pubTimestamp":1734104580,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Centene CorporationCNC recently revealed its 2025 outlook at its investor day, reaffirming its 2024 guidance.The company continues to expect premium and service revenues within $143.5-$144.5 billion, up from the 2023 figure of $140.1 billion.Adjusted earnings per share  is projected to be at least $6.80, suggesting a significant improvement from the 2023 reported figure of $6.68. The Zacks Consensus Estimate for the same is currently pegged at $6.83 per share. The company also reiterated its HBR guidance in the band of 88.3-88.5%.Centene's 2025 adjusted EPS is projected to exceed $7.25, indicating growth from the 2024 estimate of at least $6.80 per share. This underscores positive operational momentum. The 2025 adjusted EPS guidance surpasses the Zacks Consensus Estimate of $7.01 per share. It continues to expect adjusted profit to achieve an average annual growth of 12-15% over the long term.The Zacks Consensus Estimate for CareDx’s current-year earnings indicates a 167.2% year-over-y","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","BK4588":"碎股","BK4154":"管理型保健护理","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","BK4196":"保健护理服务","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","CDNA":"CareDx","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","MD":"Pediatrix Medical","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","BK4185":"保健护理机构","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","EHC":"Encompass Health Corporation","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","BK4585":"ETF&股票定投概念","BK4139":"生物科技","CNC":"康西哥","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC"},"translate_title":"Centene公布2025年指引，重申2024年展望","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MD":1,"CDNA":1,"CNC":1,"EHC":1},"content_text":"Centene Corporation CNC recently revealed its 2025 outlook at its investor day, reaffirming its 2024 guidance.The company continues to expect premium and service revenues within $143.5-$144.5 billion, up from the 2023 figure of $140.1 billion.\nAdjusted earnings per share (EPS) is projected to be at least $6.80, suggesting a significant improvement from the 2023 reported figure of $6.68. The Zacks Consensus Estimate for the same is currently pegged at $6.83 per share. The company also reiterated its HBR guidance in the band of 88.3-88.5%.\n2025 Outlook\nCentene expects total revenues within $166.5-$169.5 billion, higher than the 2024 expected figure of $159-$161 billion. The company estimates premium and service revenues to be in the $154-$156 billion range, higher than the 2024 guided range. Factors contributing to year-over-year growth include rate increases, expansion into new markets for Medicaid, continued growth in individual health insurance, rising number of uninsured individuals for Marketplace and dual expansions, and improvements in Star ratings for Medicare business.\nCentene's 2025 adjusted EPS is projected to exceed $7.25, indicating growth from the 2024 estimate of at least $6.80 per share. This underscores positive operational momentum. The 2025 adjusted EPS guidance surpasses the Zacks Consensus Estimate of $7.01 per share. It continues to expect adjusted profit to achieve an average annual growth of 12-15% over the long term.\nCentene expects the health benefits ratio to be within 88.4-89% in 2025. The company also estimates the adjusted SG&A expense ratio to be in the 8.1-8.7% range. It projects the adjusted effective tax rate between 22% and 23%.\nDiluted shares outstanding for 2025 are expected to be 491-494 million. It anticipates to repurchase shares worth $2 billion in late 2025. CNC also expects to achieve its long-term revenue growth CAGR of 7-8%. Medicaid is expected to grow 6-7%, Marketplace in the mid to high single digits, and Medicare in the high single digits to 10% in the long term.\nCNC’s Price Performance\nCentene’s shares have plunged 24.3% in the year-to-date period compared with the industry’s 11.4% decline.\nImage Source: Zacks Investment Research\nCNC's Zacks Rank & Key Picks\nCentene currently carries a Zacks Rank #3 (Hold).\nSome better-ranked and promising stocks in the broader Medical sector are Pediatrix Medical Group, Inc. MD, CareDx, Inc. CDNA and Encompass Health Corporation EHC. Each stock presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.\nThe Zacks Consensus Estimate for Pediatrix Medical’s current-year earnings indicates 7.1% year-over-year growth. MD beat earnings estimates in three of the trailing four quarters and met once, with an average surprise of 9.9%. The consensus mark for its current-year revenues is pegged at $2 billion.\nThe Zacks Consensus Estimate for CareDx’s current-year earnings indicates a 167.2% year-over-year improvement. CDNA beat earnings estimates in each of the trailing four quarters, with an average surprise of 135.2%. The consensus mark for revenues implies 17.5% growth from the year-ago period.\nThe Zacks Consensus Estimate for Encompass Health’s 2024 earnings implies a 17.6% increase from the year-ago reported figure. EHC beat earnings estimates in each of the trailing four quarters, with an average surprise of 13.6%. The consensus mark for its current-year revenues is pegged at $5.34 billion, which indicates an 11.2% year-over-year increase.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nPediatrix Medical Group, Inc. (MD) : Free Stock Analysis Report\nCentene Corporation (CNC) : Free Stock Analysis Report\nCareDx, Inc. (CDNA) : Free Stock Analysis Report\nEncompass Health Corporation (EHC) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491056543"}